RegMed Investors’ (RMi) closing bell: home in the sector’s range follow-on lyrics …

June 21, 2018 5:31pm

Oh give me a sector where the upside is sustainable,

Flows leisurely up in the market;

Where the graceful “swans” go gliding along,

Like an investor in a heavenly dream,

Oh give me a home where the algorithms don’t roam!

Pre-open indications: 7 HITs and 0 MISS

Out and about: Mesoblast (MESO)   jumped +$0.52 or +9.39% to $6.06 after the Australian company unveiled data from a clinical trial for a potential treatment for children with steroid refractory acute Graft Versus Host Disease (aGVHD). The P3 study evaluating a stem cell product candidate, remestemcel-L, enrolled 55 children aged between two months and 17 years in the U.S. Top-line day 100 results showed an 87% survival rate and an overall survival rate of 75%.

It’s a duty and an honor to being a “canary in a coal mine”!  What’s left when one is right so often? RMi is the source investors and traders need – it’s more than opinion, the facts and truth need to be recognized!

Henry’omics:

Of the 45 companies covered the 36 downside equities finished in a range of -$0.02 to -$2.96 followed by the biggest bottom of -$6.50 and $3.71 while the 9 upside equities oscillated from +$0.06 to $1.33 with toppers ranging from $6.67 to $4.25 with 0 flat closes

From the pre-open newsletter … "home in the sector’s range, where the overbought and oversold play, where seldom is heard a fair value word, and the indexes are not up each day.”

I also stated, “Thursday’s theme for the session was – Caution”

When one is RIGHT – there is NO need for a secondary response!

Pre-open indications:

• Caladrius Biosciences (CLBS) closed down -$1.49 – hit;
• CRSPR Therapeutics (CRSP) closed down -$0.12 – hit;
• Fate Therapeutics (FATE) closed down -$0.40 – hit;
• Verastem Oncology (VSTM) closed down -$0.78 – hit;
• uniQure N.V. (QURE) closed down -$0.44 – hit;
• Solid Bioscience (SLDB) closed up +$6.67 – hit;
• Voyager Therapeutics (VYGR) closed up +$1.33 – hit;

The advance/decline line scenario of 45 covered companies:   

• The open was negative with an A/DL of 18/24 and 3 flats;
• The mid-day continued negative with an A/DL of 9/34 and 2 flat;
• The close was negative with an A/DL of 9/36 and 0 flat;

MY working five (5) trend lines:

… The greatest volume to the downside:  SGMO, VSTM, MDXG, ATHX and CLBS

… Upside volume was weighted to:  VYGR, BMRN, SLDB, BLUE and RGNX

… Biggest $ downside:  RENE.L (-$6.00), SAGE (-$3.71), RARE (-$2.96), ALNY (-$2.57) and ONCE (-$2.10)

… Best moves to the $ upside: SLDB (+$6.67), BLUE (+$4.25), VTGR (+$1.33), RGNX (+$0.75) and MESO (+$0.52)

… Flats:  NONE

June sessions:

• Thursday closed NEGATIVE with 36 decliners, 9 advancers and 0 flat;
• Wednesday closed POSITIVE with 11 decliners, 31 advancers and 3 flats;
• Tuesday closed NEGATIVE with 19 decliners, 24 advancers and 2 flat;
• Monday (June 18) closed NEGATIVE with 22 decliners, 21 advancers and 2 flat;
• Friday closed POSITIVE with 16 decliners, 23 advancers and 6 flat;
• Thursday closed POSITIVE with 18 decliners, 26 advancers and 1 flat;
• Wednesday closed POSITIVE with 20 decliners, 22 advancers and 3 flats;
• Tuesday closed POSITIVE with 17 decliners, 27 advancers and 1 flat;
• Monday (June 11) closed NEGATIVE with 26 decliners, 18 advancers and 1 flat;
• Friday closed NEUTRAL with 22 decliners, 22 advancers and 1 flat;
• Thursday closed NEGATIVE with 34 decliners, 9 advancers and 2 flat;
• Wednesday closed POSITIVE with 17 decliners, 24 advancers and 4 flat;
• Tuesday closed POSITIVE with 14 decliners, 30 advancers and 1 flat;
• Monday (June 4) closed POSITIVE with 18 decliners, 25 advancers and 2 flat;
• Friday (June 1) closed was POSITIVE with 15 decliners, 29 advancers and 1 flat;

Daily analytics and metrics   – notice the patterns:

• The Dow dropped 196.1 points to 24,461.70 also posted an eight-day losing streak, its longest since March 2017.
• The S&P 500 declined 0.6% to 2,749.76.
• The NASDAQ pulled back 0.9% to 7,712.95, erasing earlier gains.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market,

• Thursday traded at 14.66, up +14.62%
• Wednesday traded at 12.79, down -4.19%
• Tuesday traded at 13.35, up +8.45%
• Monday traded at 12.31, up +2.75%
• Friday traded at 11.95, down -1.40%
• Last Thursday traded at 12.12, down -6.34 %

The iShares Russell 2000 (IWM) closed:

• Thursday was down -0.96%;
• Wednesday was up +0.81%;
• Tuesday was up +0.04%;
• Monday was up +0.48%;
• Friday was down -0.04%;
• Last Thursday was up +0.54%;

The iShares NASDAQ Biotechnology (IBB) closed:

• Thursday was down -1.13 %
• Wednesday was up +1.66%
• Tuesday was up +1.46%
• Monday was down -0.75%
• Friday was down -0.11%
• Last Thursday was up +0.81%

The count in June - decliners versus gainers:

……. look at the differences in decliners:

• Thursday’s decliners ranged from -0.18% <CRSP -$0.12 > to -17.25% < CLBS -$1.49> in 36 equities;
• Wednesday’s decliners ranged from -0.28% < STML -$0.05> to -17.05% <SLDB -$7.33> in 11 equities;
• Tuesday’s decliners ranged from -1.52% <ALNY -$1.61 > to -0.23% <BCLI -$0.01 > in 19 equities;
• Monday’s decliners ranged from -0.28% <STML -$0.05 > to -9.47% <BLCM -$0.94 > in 22 equities;
• Friday’s decliners ranged from -0.32% < VYGR -$0.07> to -15.95% < CUR -$0.26> in 16 equities;
• Last Thursday’s decliners ranged from -0.43% <ATHX -$0.01 > to -5.41% <VCEL -$0.70 > in 18 equities;

Versus

… Look at the percentage’s (%) and spreads …

• Thursday’s gainers ranged from +0.09% <BMRN +$0.09 > to +18.7% <SLDB +$6.67 > in 9 equities;
• Wednesday’s gainers ranged from +0.06% <XON +$0.01> to +30.71% <CLBS +$2.03 > in 31 equities;
• Tuesday’s gainers ranged from +0.04% <BMRN +$0.04 > to +46.36% <SLDB +$13.62 > in 24 equities;
• Monday’s gainers ranged from +0.43% <BTX +$0.01 > to +31.39% <VSTM +$2.05 > in 20 equities;
• Friday’s gainers ranged from +0.06% <SAGE +$0.10 > to +17.03% < VSTM +$0.95> in 23 equities;
• Thursday’s gainers ranged from +0.10% < BOLD +$0.04> to +8.45% <ADRO +$0.60 > in 26 equities;

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.